Europe, Alterity and Fear in French Classical Drama : Past Plots and Contemporary Controversies

Alguns conceptes d'Europa són explícitament exposats en diversos drames clàssics francesos dels segles xvii i xviii. Implícitament es plantegen assumptes europeus quan les cultures no europees es representen en formes que impliquin un contrast amb la cultura europea. Les obres aquí examinades de Desmarets de Saint-Sorlin, Molière, Racine, Voltaire i Lemierre susciten una immediata reflexió sobre dos temes recurrents en la història europea: en primer lloc, el temor que una part d'Europa, una religió o una ideologia, hagi d'exercir un control hegemònic sobre la resta d'Europa; en segon lloc, l'anhel europeu d'eliminar les formes radicals de l'alteritat quan se la troben en altres continents. La recepció contemporània d'algunes d'aquestes obres demostra que encara poden ser molt controvertides.Concepts of Europe are explicitly treated in several French classical dramas of the seventeenth and eighteenth centuries. European issues are also raised implicitly when non-European cultures are depicted in ways which imply a contrast with European culture. The plays examined here by Desmarets de Saint-Sorlin, Molière, Racine, Voltaire and Lemierre prompt reflection on two recurrent themes in European history: firstly, the fear that one part of Europe, one religion, or one ideology, should exercise hegemonic control over the rest of Europe; secondly, European aspirations to eliminate radical forms of alterity when encountered in other continents. The contemporary reception of some of these plays proves that they can still be highly controversial

Use of the Randox Evidence Investigator immunoassay system for near-body drug screening during post-mortem examination in 261 forensic cases

BackgroundThis paper describes the performance of four Randox drug arrays, designed for whole blood, for the near-body analysis of drugs in a range of post-mortem body specimens.MethodsLiver, psoas muscle, femoral blood, vitreous humor and urine from 261 post-mortem cases were screened in the mortuary and results were obtained within the time taken to complete a post-mortem. Specimens were screened for the presence of amfetamine, barbiturates, benzodiazepines, benzoylecgonine, buprenorphine, cannabinoids, dextropropoxyphene, fentanyl, ketamine, lysergide, methadone, metamfetamine, methaqualone, 3,4-methylenedioxymetamfetamine, opioids, paracetamol, phencyclidine, salicylate, salicylic acid, zaleplon, zopiclone and zolpidem using the DOA I, DOA I+, DOA II and Custom arrays.ResultsLiver and muscle specimens were obtained from each of the 261 post-mortem cases; femoral blood, vitreous humor and urine were available in 98%, 92% and 72% of the cases, respectively. As such, the equivalent of 12,978 individual drug-specific, or drug-group, immunoassay tests were undertaken. Overall >98% of the 12,978 screening tests undertaken agreed with laboratory confirmatory tests performed on femoral blood.ConclusionsThere is growing interest in the development of non-invasive procedures for determining the cause of death using MRI and CT scanning however these procedures are, in most cases, unable to determine whether death may have been associated with drug use. The Randox arrays can provide qualitative and semi-quantitative results in a mortuary environment enabling pathologists to decide whether to remove specimens from the body and submit them for laboratory analysis. Analysis can be undertaken on a range of autopsy specimens which is particularly useful when conventional specimens such as blood are unavailable

Applying life cycle assessment with minimal information to support early-stage material selection

Traditional life cycle assessment (LCA) is too data intensive and time consuming to be used during typical building design processes. Conducting an LCA during the building design process therefore requires simplifications and assumptions. Such “screening LCAs” are quicker and can be used with less data but introduce greater uncertainty. Unfortunately, uncertainty is not reflected in standard deterministic LCA calculations, which produce single-point values in LCA results. Thus, in this study, data quality scoring has been incorporated into a screening LCA to produce probabilistic predictions of environmental performance based on limited data. The approach has been applied during the design process of a bio-based wall panel designed for a circular economy. A combination of ecoinvent and material data sheets were used to analyse a wide range of novel bio-based insulation materials. The screening LCA analysed global warming potential and identified a short-list of promising materials that were then subjected to a detailed LCA for further consideration in the design. The method uses publicly available information and can be applied at material or building-element level. The method thus helps designers estimate environmental impacts without hindering the design process

Biomarkers in mesothelioma

Mesothelioma is an aggressive cancer of pleural and peritoneal cells that is difficult to diagnose and monitor. Numerous studies have attempted to identify a blood- or pleural fluid-based biomarker that could be used in the diagnostic pathway. More recently, there has been interest in the ability of serum/plasma biomarkers to monitor mesothelioma, given the development of newer treatments and limitations of radiological assessment. The majority of research has focused on soluble mesothelin, a soluble glycoprotein expressed by mesothelial cells. Although soluble mesothelin lacks the sensitivity to be used as a standalone diagnostic marker, serial measurements may be informative, with rising concentrations indicating disease progression and poor survival. High concentrations of other soluble glycoproteins, such as osteopontin, fibulin-3 and vascular endothelial growth factor are independently associated with poor prognosis at baseline, although further research is required to ascertain any role outside of clinical trials. More recent literature has focused on the development of novel biomarkers from discovery cohorts. Although many DNA and mRNA biomarkers show promise in the diagnosis or screening of mesothelioma, none have been prospectively evaluated for use in clinical practice. In this review article, we highlight the potential utility of biomarkers and evaluate the existing literature. </jats:p

The status of Habitats Directive Annex I saltmarsh habitats, transition zones and spartina species in England

On unmodified soft sediment coastlines, of which there are long lengths especially on the English east and south coasts, there should be a wide transitional zone between tidal areas and full terrestrial land. The conditions in this zone result in a rich and distinctive range of habitats. There are two saltmarsh habitats listed in Annex I of the Habitats Directive within this zone (H1420 Mediterranean and thermo-Atlantic halophilous scrubs and H1320 Spartina swards,Spartinion maritimae) reflecting its importance for nature conservation. At the time work for this project was started in 2012, the conservation status of these habitats was reported as ‘unfavourable, bad and deteriorating’. Due to construction of artificial sea defences, these zones are now much reduced in extent and distribution and are under threat from a range of factors. This project aims to provide an inventory and description of Annex I saltmarsh habitats and transitional vegetation in England. This will help to update future reporting on conservation status. The outcomes will also help improve understanding of the underpinning processes which can be used in design to improve the potential for recreating these elements of saltmarshes as part of intertidal restoration schemes. The project also provides an up to date assessment of Spartina alterniflora stands in the Solent SAC through review and field survey for 2012

Search Engine for Antimicrobial Resistance: A Cloud Compatible Pipeline and Web Interface for Rapidly Detecting Antimicrobial Resistance Genes Directly from Sequence Data.

BACKGROUND: Antimicrobial resistance remains a growing and significant concern in human and veterinary medicine. Current laboratory methods for the detection and surveillance of antimicrobial resistant bacteria are limited in their effectiveness and scope. With the rapidly developing field of whole genome sequencing beginning to be utilised in clinical practice, the ability to interrogate sequencing data quickly and easily for the presence of antimicrobial resistance genes will become increasingly important and useful for informing clinical decisions. Additionally, use of such tools will provide insight into the dynamics of antimicrobial resistance genes in metagenomic samples such as those used in environmental monitoring. RESULTS: Here we present the Search Engine for Antimicrobial Resistance (SEAR), a pipeline and web interface for detection of horizontally acquired antimicrobial resistance genes in raw sequencing data. The pipeline provides gene information, abundance estimation and the reconstructed sequence of antimicrobial resistance genes; it also provides web links to additional information on each gene. The pipeline utilises clustering and read mapping to annotate full-length genes relative to a user-defined database. It also uses local alignment of annotated genes to a range of online databases to provide additional information. We demonstrate SEAR's application in the detection and abundance estimation of antimicrobial resistance genes in two novel environmental metagenomes, 32 human faecal microbiome datasets and 126 clinical isolates of Shigella sonnei. CONCLUSIONS: We have developed a pipeline that contributes to the improved capacity for antimicrobial resistance detection afforded by next generation sequencing technologies, allowing for rapid detection of antimicrobial resistance genes directly from sequencing data. SEAR uses raw sequencing data via an intuitive interface so can be run rapidly without requiring advanced bioinformatic skills or resources. Finally, we show that SEAR is effective in detecting antimicrobial resistance genes in metagenomic and isolate sequencing data from both environmental metagenomes and sequencing data from clinical isolates.This research was funded by GlaxoSmithKline, the Centre for Environment, Fisheries and Aquaculture Science and the Biotechnology and Biological Sciences Research Council under an industrial CASE studentship. The funder Centre for Environment, Fisheries and Aquaculture Science provided support in the form of salaries, research materials and facilities for authors DVJ and CBA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder GlaxoSmithKline provided support in the form of salaries for author JR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.This is the final version. It was first published by PLOS at http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0133492